$GNPX Cashflow Statement | Understand Stock

$GNPX

$2.01 +$0.06 (3.08%) Close

Financial Statements

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Share-based compensation
Excluding ELOC Purchase Agreement
The 2025 ELOC Facility
Total share-based compensation
Intellectual property
Changes in operating assets and liabilities:
Accounts receivable
Prepaid expenses and other
Research and development supplies
Deposits
Accounts payable
Other current liabilities
Net cash used in operating activities
Cash flows from investing activities:
Additions to property and equipment
Disposals of property and equipment
Additions to intellectual property
Additions to research and development supplies
Reductions (additions) to research and development supplies
Reductions to intellectual property
Net cash provided by investing activities

Cash flows from financing activities:
Net proceeds from issuances of common stock
The 2025 ELOC Facility
Total net proceeds from issuances of common stock
Net cash provided by financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year
Supplemental schedule of non-cash investing and financing activities:
Deemed dividend related to warrant modification

Comments